CRISPR and HIV

Clinical data presented at the ASGCT meeting in Baltimore last week revealed that Excision Biotherapeutics' CRISPR-based therapy for HIV is safe but...

Researchers at Universidade de São Paulo in Brazil review progress in recent years involving the use of gene editing to cure HIV and prevent...

Excision BioTherapeutics reported positive interim clinical data for its HIV therapeutic candidate EBT-101 at this year's European Society for Gene &...

A one-shot CRISPR cure for HIV may be in sight with a new approach that eliminated replication-competent virus in 58% of infected mice. The method...

A recent study reports the first ever application of base editing to protect immune cells against HIV infection. This is achieved without introducing...

Researchers at Texas Biomedical Research Institute in San Antonio, Texas have developed a novel strategy to inhibit human immunodeficiency virus (HIV)...

In 2021, we've seen positive clinical data for the first ever in vivo CRISPR medicines, base editors are heading for the clinic, and CRISPR therapies...

This week, we look at a CRISPR-based therapy for HIV that has just passed the IND approval stage, and will soon be tested in a Phase 1/2 clinical...